Exportar registro bibliográfico


Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development (2018)

  • Authors:
  • Unidades: FM
  • DOI: 10.1038/gim.2017.163
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Informações sobre o DOI: 10.1038/gim.2017.163 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by-nc-nd

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BAETENS, Dorien; MENDONÇA, Berenice Bilharinho de. Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development. Genetics in medicine, New York, v. 20, n. 7, p. 717-727, 2018. Disponível em: < http://dx.doi.org/10.1038/gim.2017.163 > DOI: 10.1038/gim.2017.163.
    • APA

      Baetens, D., & Mendonça, B. B. de. (2018). Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development. Genetics in medicine, 20( 7), 717-727. doi:10.1038/gim.2017.163
    • NLM

      Baetens D, Mendonça BB de. Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development [Internet]. Genetics in medicine. 2018 ; 20( 7): 717-727.Available from: http://dx.doi.org/10.1038/gim.2017.163
    • Vancouver

      Baetens D, Mendonça BB de. Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development [Internet]. Genetics in medicine. 2018 ; 20( 7): 717-727.Available from: http://dx.doi.org/10.1038/gim.2017.163

    Referências citadas na obra
    Ono M, Harley VR. Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol 2013;9:79–91.
    Pearlman A, Loke J, Le Caignec C et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet 2010;87:898–904.
    Bogani D, Siggers P, Brixey R et al. Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol 2009;7:e1000196.
    Warr N, Bogani D, Siggers P et al. Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP3K1. PLoS ONE 2011;6:e19572.
    Uhlenhaut NH, Jakob S, Anlag K et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 2009;139:1130–1142.
    Matson CK, Murphy MW, Sarver AL, Griswold MD, Bardwell VJ, Zarkower D. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 2011;9:1–5.
    Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child 2006: 554–563.
    Bashamboo A, Ledig S, Wieacker P, Achermann J, McElreavey K. New technologies for the identification of novel genetic markers of disorders of sex development (DSD). Sex Dev 2010;15:213–224.
    Baxter RM, Arboleda VA, Lee H et al. Exome sequencing for the diagnosis of 46, XY disorders of sex development. J Clin Endocrinol Metab 2015;100:E333–E344.
    Cools M, Wolffenbuttel KP, Drop SLS, Oosterhuis JW, Looijenga LHJ. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 2011;5:167–180.
    Ferraz-de-Souza B, Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol 2011;336:198–205.
    Mongan N, Tadokoro-Cuccaro R, Bunch T, Hughes I. Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab 2015;29:569–580.
    Orekhova AS, Rubtsov PM. DAX1, an unusual member of the nuclear receptor superfamily with diverse functions. Mol Biol 2015;49:65–76.
    Coppieters F, Van Schil K, Bauwens M et al. Identity-by-descent-guided mutation analysis and exome sequencing in consanguineous families reveals unusual clinical and molecular findings in retinal dystrophy. Genet Med 2014;16:671–680.
    Tranchevent L-C, Capdevila FB, Nitsch D, De Moor B, De Causmaecker P, Moreau Y. A guide to web tools to prioritize candidate genes. Brief Bioinform 2011;12:22–32.
    De Leeneer K, Hellemans J, Steyaert W et al. Flexible, scalable, and efficient targeted resequencing on a benchtop sequencer for variant detection in clinical practice. Hum Mutat 2015;36:379–387.
    Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–424.
    Schwabe JWR, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993;75:567–578.
    Krieger E, Joo K, Lee J et al. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 2009;77:114–122.
    Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 2002;320:369–387.
    Möcklinghoff S, Rose R, Carraz M, Visser A, Ottmann C, Brunsveld L. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain. Chembiochem 2010;11:2251–2254.
    Pettersen EF, Goddard TD, Huang CC et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–1612.
    Gerrard DT, Berry AA, Jennings RE, Hanley KP, Bobola N, Hanley NA. An integrative transcriptomic atlas of organogenesis in human embryos. eLlife 2016;5:1–16.
    Del Valle I, Buonocore F, Duncan AJ et al. A genomic atlas of human adrenal and gonad development. Wellcome Open Res 2017;2:25.
    Ban S, Sata F, Kurahashi N et al. Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias. Hum Reprod 2008;23:1466–1471.
    Beleza-Meireles A, Omrani D, Kockum I, Frisén L, Lagerstedt K, Nordenskjöld A. Polymorphisms of estrogen receptor β gene are associated with hypospadias. J Endocrinol Invest 2006;29:5–10.
    Beleza-Meireles A, Kockum I, Lundberg F, Söderhäll C, Nordenskjöld A. Risk factors for hypospadias in the estrogen receptor 2 gene. J Clin Endocrinol Metab 2007;92:3712–3718.
    Van der Zanden LFM, van Rooij IALM, Feitz WFJ, Franke B, Knoers NVAM, Roeleveld N. Aetiology of hypospadias: a systematic review of genes and environment. Hum Reprod Update 2012;18:260–283.
    Van der Zanden LF, van Rooij IA, Feitz WF, Franke B, Knoers NV, Roeleveld N. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2 ESR1 ESR2, and ATF3 really associated with the malformation? J Clin Endocrinol Metab 2010;95:2384–2390.
    Asadi M, Ghafouri-Fard S, Zare-Abdollahi D, Ebrahim-Habibi A, Matin N. Estrogen receptor mutation in a girl with primary amenorrhea. Clin Genet 2013;83:497–498.
    Drummond AE, Fuller PJ. The importance of ERbeta signalling in the ovary. J Endocrinol 2010;205:15–23.
    Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006;7:497–508.
    Loke J, Pearlman A, Radi O et al. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Hum Mol Genet 2014;23:1073–1083.
    Ostrer H. Disorders of sex development (DSDs): an update. J Clin Endocrinol Metab 2014;99:1503–1509.
    Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001;64:65–92.
    Segars JH, Driggers PH. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab 2002;13:349–354.
    Driggers PH, Segars JH. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 2002;13:422–427.
    Krege JH, Hodgin JB, Couse JF et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998;95:15677–15682.
    Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-badge R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761–767.
    Coppieters F, Leroy BP, Beysen D et al. Recurrent mutation in the first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa. Am J Hum Genet 2007;81:147–157.

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020